Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

70 ta ish

Ish: Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

  1. Fitting Linear Mixed-Effects Models Using <b>lme4</b>

    Douglas M. Bates, Martin Mächler, Benjamin M. Bolker +1

    MaqolaOchiq kirish201522 iqtibos
    ABI

  2. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

    Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

    MaqolaOchiq kirish201012 iqtibos
    ABI

  3. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

    Shama D. Ahuja, David Ashkin, Monika Avendano +70

    Sharh maqolaOchiq kirish20129 iqtibos
    ABI

  4. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

    Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves +32

    MaqolaOchiq kirish20167 iqtibos
    ABI

  5. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

    Andrew Nunn, Patrick Phillips, Sarah Meredith +16

    MaqolaOchiq kirish20196 iqtibos
    ABI

  6. High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

    Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5

    Maqola20146 iqtibos
    ABI

  7. Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

    K. J. M. Aung, Armand Van Deun, Erik De Clercq +4

    Maqola20146 iqtibos
    ABI

  8. Conducting Meta-Analyses in<i>R</i>with the<b>metafor</b>Package

    Wolfgang Viechtbauer

    MaqolaOchiq kirish20106 iqtibos
    ABI

  9. Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries

    Arnaud Trébucq, V Schwoebel, Zacharie Kashongwe +15

    Maqola20176 iqtibos
    ABI

  10. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

    Christopher Kuaban, J Noeske, Hans L. Rieder +3

    MaqolaOchiq kirish20155 iqtibos
    ABI

  11. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

    Faiz Ahmad Khan, M Salim, Philipp du Cros +9

    Sharh maqolaOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos
    ABI

  12. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

    Sharh maqolaOchiq kirish20204 iqtibos
    ABI

  13. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis

    Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies

    Sharh maqolaOchiq kirish20174 iqtibos
    ABI

  14. Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection

    Maryline Bonnet, Manuela Pardini, Francesca Meacci +14

    MaqolaOchiq kirish20114 iqtibos
    ABI

  15. <b>mice</b>: Multivariate Imputation by Chained Equations in<i>R</i>

    Stef van Buuren, Karin Groothuis‐Oudshoorn

    MaqolaOchiq kirish20114 iqtibos
    ABI

  16. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

    Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

    Sharh maqolaOchiq kirish20144 iqtibos
    ABI

  17. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

    Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch +13

    MaqolaOchiq kirish20144 iqtibos
    ABI

  18. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

    Sharh maqolaOchiq kirish20184 iqtibos
    ABI

  19. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

    J. Peter Cegielski, Ekaterina V. Kurbatova, Martie van der Walt +74

    MaqolaOchiq kirish20153 iqtibos
    ABI

  20. Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis

    Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +18

    BoshqaOchiq kirish20163 iqtibos
    ABI

  21. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

    Peter C. Austin

    MaqolaOchiq kirish20113 iqtibos
    ABI

  22. Sarlavhasiz

    BoshqaOchiq kirish3 iqtibos
    ABI

  23. The binomial distribution of meta-analysis was preferred to model within-study variability

    Taye H. Hamza, Hans C. van Houwelingen, Theo Stijnen

    Maqola20072 iqtibos
    ABI

  24. Patterns of Treatment Interruption among Patients with Multidrug-Resistant TB (MDR TB) and Association with Interim and Final Treatment Outcomes

    Laura Jean Podewils, Maria Tarcela Gler, Maria Imelda Quelapio +1

    MaqolaOchiq kirish20132 iqtibos
    ABI

  25. Sarlavhasiz

    BoshqaOchiq kirish2 iqtibos
    ABI